[1] This was the first conference after the technological advance of being able to measure HIV viral load.
[2] A study presented showed that United States military had higher risk of HIV infection.
[3] The conference presented the introduction of combination therapy using protease inhibitors.
[4] ADARC's David Ho and his team showed their clinicial trial results.
[5] Within a week after the conference, over 75,000 patients who had been using antibiotics and chemotherapy as treatment against opportunistic infections began an effective antiviral regimen which greatly increased their immune system strength and therefore their health.